NCT04545411: A reported trial by University of California, San Diego
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04545411 |
|---|---|
| Title | Effect of Glucagon Receptor Antagonism on Ketogenesis in SGLT-2i Treated Subjects With T1D |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 22, 2021 |
| Completion date | Feb. 28, 2022 |
| Required reporting date | Feb. 28, 2023, midnight |
| Actual reporting date | Feb. 2, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |